Condition (MeSH)
Reproductive Tract Infections
ClinicalTrials.gov lists 2 trials for Reproductive Tract Infections or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with Reproductive Tract Infections itself; the rest are tagged with a narrower condition beneath it.
When did Reproductive Tract Infections trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2013 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Reproductive Tract Infections trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Not applicable | 1 |
How many Reproductive Tract Infections trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which serious adverse events do Reproductive Tract Infections trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Congenital anomoly | 27 | 1 |
| Anemia | 16 | 1 |
| Neutropenia | 11 | 1 |
| Post-partum hemmorrha | 7 | 1 |
| Pre-eclampsia | 5 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Reproductive Tract Infections? (35)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE). | BMC medicine | 2023 | Yes |
| Genital tract infections, the vaginal microbiome and gestational age at birth among pregnant women in South Africa: a cohort study protocol. | BMJ open | 2023 | Yes |
| Feasibility and acceptability of frequent vaginal self-sampling at home by Rwandan women at high risk of urogenital tract infections. | Sexually transmitted infections | 2022 | Yes |
| Risk-based screening to identify reproductive tract infection among HIV-infected women desiring use of intrauterine contraceptives. | BMJ sexual & reproductive health | 2021 | Yes |
| Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials. | Diabetes, obesity & metabolism | 2017 | Yes |
Showing 5 of 35 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.